Susquehanna International Group
SRTA

Susquehanna International Group’s Strata Critical Medical Inc SRTA Stock Holding History

Susquehanna International Group’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$148K Buy
35,400
+11,800
+50% +$56.8K ﹤0.01% 12017
2025
Q4 		$114K Sell
23,600
-380,800
-94% -$1.84M ﹤0.01% 11381
2025
Q3 		$2.05M Buy
404,400
+9,400
+2% +$41.5K ﹤0.01% 5752
2025
Q2 		$1.59M Buy
395,000
+367,700
+1,347% +$1.2M ﹤0.01% 6288
2025
Q1 		$74.5K Buy
27,300
+11,700
+75% +$42K ﹤0.01% 11712
2024
Q4 		$66.3K Buy
+15,600
New +$59.4K ﹤0.01% 11562
2024
Q2 		– Sell
-33,700
Closed -$96K – 12059
2024
Q1 		$96K Buy
+33,700
New +$104K ﹤0.01% 11242
2022
Q4 		– Sell
-14,900
Closed -$60K – 12434
2022
Q3 		$60K Sell
14,900
-5,100
-26% -$26.2K ﹤0.01% 12088
2022
Q2 		$89K Sell
20,000
-57,100
-74% -$412K ﹤0.01% 11571
2022
Q1 		$655K Sell
77,100
-116,300
-60% -$817K ﹤0.01% 8248
2021
Q4 		$1.71M Buy
193,400
+10,800
+6% +$103K ﹤0.01% 5889
2021
Q3 		$1.9M Buy
182,600
+7,300
+4% +$63.8K ﹤0.01% 5946
2021
Q2 		$1.84M Sell
175,300
-72,300
-29% -$714K ﹤0.01% 6106
2021
Q1 		$2.55M Buy
+247,600
New +$3.44M ﹤0.01% 5336

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's SRTA Position: Q1 2026 in Review

Susquehanna International Group reduced its Strata Critical Medical Inc (SRTA) stake by 3.1% in Q1 2026, selling an estimated $4.13K and leaving 26,661 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #12268.

Susquehanna International Group first reported a position in SRTA in Q1 2021 and has held it in 21 quarters since. The position peaked at $3.74M in Q1 2021. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Susquehanna International Group held 26,661 shares of Strata Critical Medical Inc worth $111K as of Q1 2026.
  • Susquehanna International Group sold 859 Strata Critical Medical Inc shares in Q1 2026, an estimated $4.13K.
  • Strata Critical Medical Inc made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12268 holding.
  • Susquehanna International Group first reported a position in Strata Critical Medical Inc in Q1 2021 and has held it in 21 quarters since.
  • Susquehanna International Group's Strata Critical Medical Inc position peaked at $3.74M in Q1 2021.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.